Valneva SE (VALN) Invested Capital (2020 - 2026)
Valneva SE (VALN) posted Invested Capital of $21.4 million for Q1 2026, down 89.75% sequentially from $208.6 million in Q4 2025, and up 3.2% YoY from $20.7 million in Q1 2025.
Analysis
Valneva SE (VALN) Invested Capital (2020 - 2026) Analysis & Trends
Valneva SE has reported Invested Capital for 8 years, with the latest figure at $21.4 million in Q1 2026.
- Quarterly Invested Capital rose 3.2% year-over-year to $21.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $489.4 million (up 12.09% YoY) and the FY2025 annual result came in at $208.6 million, up 2.86% from the prior year.
- Invested Capital fell to $21.4 million in Q1 2026 per VALN's latest filing, from $208.6 million in the prior quarter.
- Over five years, Invested Capital peaked at $208.6 million in Q4 2025 and troughed at $12.6 million in Q3 2022.
- A 5-year average of $84.8 million and a median of $36.8 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2023 and 2024: Invested Capital slumped 80.61% in 2023, then jumped 741.81% in 2024.
- Over 5 years, Invested Capital stood at $91.0 million in 2022, then soared by 98.09% to $180.2 million in 2023, then increased by 11.09% to $200.2 million in 2024, then climbed by 4.18% to $208.6 million in 2025, then sank by 89.75% to $21.4 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $21.4 million, $208.6 million, and $68.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Valneva SE | 580.64 Mn | 439.38 Mn | 1.86 Mn | 500.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 500.76 Mn |
| Mar 31, 2026 | 303.26 Mn |
| Dec 31, 2025 | 519.86 Mn |
| Sep 30, 2025 | 371.99 Mn |
| Jun 30, 2025 | 401.64 Mn |
| Mar 31, 2025 | 374.93 Mn |
| Dec 31, 2024 | 393.91 Mn |
| Sep 30, 2024 | 428.36 Mn |
| Jun 30, 2024 | 546.24 Mn |
| Mar 31, 2024 | 402.69 Mn |
| Dec 31, 2023 | 328.26 Mn |
| Sep 30, 2023 | 799.96 Mn |
| Jun 30, 2023 | 311.56 Mn |
| Mar 31, 2023 | 339.52 Mn |
| Dec 31, 2022 | 718.69 Mn |
| Sep 30, 2022 | 137.08 Mn |
| Jun 30, 2022 | 114.97 Mn |
| Mar 31, 2022 | 246.77 Mn |
| Dec 31, 2021 | 92.35 Mn |
| Dec 31, 2020 | 164.27 Mn |